Cervical lipomatosis in HIV‐infected patients: a case–control study

Rosario Palacios(Bellvitge University Hospital), Antonio Rivero(University of Southern California), Víctor Asensi(Baylor College of Medicine), Dolores Morales(Hospital Universitario Virgen Macarena), Fernando Lozano(Hospital Universitario de Valme), JA Arranz(Hospital Universitario Príncipe de Asturias), MJ Galindo(Hospital Clínico Universitario de Valencia), Agustín Matías Muñoz(Hospital Universitario Infanta Cristina), Vicente Estrada(Instituto de Salud Carlos III), Jesús Santos(Hospital Clínico Universitario Virgen de la Victoria)
HIV Medicine
January 1, 2007
10.1111/j.1468-1293.2007.00421.x
Cited by 9

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332